Abbott has acquired FDA approval for its molecular human papillomavirus (HPV) screening solution, bringing to the Alinity m family of diagnostic tests a strong cancer screening tool for detecting high-risk HPV infections. According to the US...
Lupin Limited (Lupin) and Zydus Lifesciences Limited (Zydus), a discovery-driven global lifesciences company, announced a licensing and supply agreement to co-market saroglitazar Mg in India for the treatment of non-alcoholic fatty liver...
Phathom Pharmaceuticals Inc, an innovative, biopharmaceutical company specializing in gastrointestinal disease treatments
Eppendorf, the renowned life science company, specializes in the development and sale of cutting-edge instruments
Bayer and the Broad Institute of MIT and Harvard have recently confirmed the continuation of their collaborative research work for another five years after a successful decade-long partnership
The unveiling of diazepam rectal gel, available in doses of 10 mg and 20 mg, has been declared by Lupin Limited
Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, has announced the availability of a new version of their distributed liquid biopsy test for genomic profiling. The TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2)...
Sun Pharma Advanced Research Company Ltd. (SPARC) announced an agreement with Johns Hopkins University (JHU) and The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB) (Licensors) to exclusively license SCD-153...
Merck (MSD) announced that the US Food and Drug Administration (FDA) has approved Keytruda, Merck's anti-PD-1 therapy, in combination with gemcitabine and cisplatin for the treatment of patients with locally advanced unresectable or metastatic...
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical firm, has announced the signing of a development contract to produce a Ketamine formulation suited for intravenous administration in accordance with current FDA manufacturing rules...